These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 29179182)

  • 1. Therapeutic Effects of FK506 on IgA Nephropathy Rat.
    Wei L; Du Y; Jia L; Ma X; Chen Z; Lu J; Tian L; Duan Z; Dong F; Lv Z; Yao G; Fu R; Wang L
    Kidney Blood Press Res; 2017; 42(6):983-998. PubMed ID: 29179182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK506 alleviates proteinuria in rats with adriamycin-induced nephropathy by down-regulating TRPC6 and CaN expression.
    Liu Y; Ji Z
    J Nephrol; 2012; 25(6):918-25. PubMed ID: 22865594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin slows IgA nephropathy progression in the rat.
    Tian J; Wang Y; Zhou X; Li Y; Wang C; Li J; Li R
    Am J Nephrol; 2014; 39(3):218-29. PubMed ID: 24603476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Jixuecao (Herba Centellae Asiaticae) alleviates mesangial cell proliferation in IgA nephropathy by inducing mitofusin 2 expression.
    Chen H; Du Y; Li Y; Zeng J; Miao J; Jiang X
    J Tradit Chin Med; 2019 Jun; 39(3):346-355. PubMed ID: 32186007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS
    J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Akt/mTOR/p70S6K pathway is activated in IgA nephropathy and rapamycin may represent a viable treatment option.
    Tian J; Wang Y; Guo H; Li R
    Exp Mol Pathol; 2015 Dec; 99(3):435-40. PubMed ID: 26297427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of recurrent IgA nephropathy following renal transplantation under tacrolimus (FK506)].
    Takao T; Hatori M; Ichimaru N; Honda M; Nonomura N; Matsumiya K; Kokado Y; Takahara S; Okuyama A; Miyamoto M; Yokoyama K; Imai E; Kyo M
    Hinyokika Kiyo; 1997 Sep; 43(9):661-4. PubMed ID: 9365847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 ameliorates podocyte injury in type 2 diabetic nephropathy by down-regulating TRPC6 and NFAT expression.
    Ma R; Liu L; Jiang W; Yu Y; Song H
    Int J Clin Exp Pathol; 2015; 8(11):14063-74. PubMed ID: 26823720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like Receptor 4 Signaling Pathway in the Protective Effect of Pioglitazone on Experimental Immunoglobulin A Nephropathy.
    Zou JN; Xiao J; Hu SS; Fu CS; Zhang XL; Zhang ZX; Lu YJ; Chen WJ; Ye ZB
    Chin Med J (Engl); 2017 Apr; 130(8):906-913. PubMed ID: 28397719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506 ameliorates proteinuria and glomerular lesions induced by anti-Thy 1.1 monoclonal antibody 1-22-3.
    Ikezumi Y; Kanno K; Koike H; Tomita M; Uchiyama M; Shimizu F; Kawachi H
    Kidney Int; 2002 Apr; 61(4):1339-50. PubMed ID: 11918741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506 ameliorates renal injury in early experimental diabetic rats induced by streptozotocin.
    Qi XM; Wu YG; Liang C; Zhang P; Dong J; Ren KJ; Zhang W; Fang F; Shen JJ
    Int Immunopharmacol; 2011 Oct; 11(10):1613-9. PubMed ID: 21640200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy.
    Zhong Q; Leung JC; Chan LY; Tsang AW; Chen X; Lai KN
    Am J Chin Med; 2005; 33(4):613-26. PubMed ID: 16173535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.
    White M; Montezano AC; Touyz RM
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):5-14. PubMed ID: 22184128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and pathological manifestations of Chinese childhood patients with primary IgA nephropathy: a national collaborative study of 33 hospitals].
    ; Jiang XY
    Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):272-8. PubMed ID: 17706064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis.
    Song YH; Cai GY; Xiao YF; Wang YP; Yuan BS; Xia YY; Wang SY; Chen P; Liu SW; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):61. PubMed ID: 28193247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin ameliorates IgA nephropathy via cell cycle-dependent mechanisms.
    Tian J; Wang Y; Liu X; Zhou X; Li R
    Exp Biol Med (Maywood); 2015 Jul; 240(7):936-45. PubMed ID: 25349217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of atorvastatin on IgA nephropathy in the rat.
    Katzir Z; Leibovitch E; Vaknin H; Schreiber L; Berger E; Matas Z; Fux A; Boaz M; Briliant A; Biro A
    Clin Nephrol; 2013 Mar; 79(3):214-20. PubMed ID: 23073067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and outcomes of IgA nephropathy with hematuria and/or minimal proteinuria.
    Tan M; Li W; Zou G; Zhang C; Fang J
    Kidney Blood Press Res; 2015; 40(2):200-6. PubMed ID: 25924707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological analysis of IgA nephropathy with crescentic formation in childhood].
    Yao Y; Liu JC; Xiao HJ; Huang JP; Yang JY
    Zhonghua Er Ke Za Zhi; 2004 Jun; 42(6):412-6. PubMed ID: 15265422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.